Intrinsiqs

Is LB Pharmaceuticals Inc Common Stock overvalued?

LB Pharmaceuticals Inc Common Stock (LBRX) — key valuation metrics and fundamentals.

No verdict
Price
$37.28
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.07B
Dividend yield
0.0%
Return on equity
-25.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LBRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.